Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Lymphatic Disease”

28,841 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 28,841 results

Testing effectiveness (Phase 2)UnknownNCT01300156
What this trial is testing

Etoposide, Methylprednisolone, High-dose Cytarabine and Oxaliplatin (ESHAOx) for Refractory or Relapsed Hodgkin's Lymphoma (HL)

Who this might be right for
Hodgkin's Lymphoma
National Cancer Center, Korea 37
Not applicableStudy completedNCT04754529
What this trial is testing

Yoga Intervention for the Improvement of Cancer-Related Stress in Cancer Survivors

Who this might be right for
Hematopoietic and Lymphoid Cell NeoplasmMalignant Solid Neoplasm
Roswell Park Cancer Institute 27
Early research (Phase 1)Ended earlyNCT02641002
What this trial is testing

CC-90002 in Subjects With Acute Myeloid Leukemia (AML) and High-risk Myelodysplastic Syndrome (MDS)

Who this might be right for
Leukemia, Myeloid, AcuteMyelodysplastic Syndromes
Celgene 28
Not applicableLooking for participantsNCT01451502
What this trial is testing

Infusion of Cell Populations From Unlicensed Umbilical Cord Blood Units

Who this might be right for
Lymphatic DiseasesHematopoietic Malignancy
Masonic Cancer Center, University of Minnesota 250
Testing effectiveness (Phase 2)UnknownNCT02851472
What this trial is testing

Prevention of Transfusion Related Acute Gut Injury (TRAGI) in Extremely Low Gestational Age Neonates (ELGANs) Using iNO

Who this might be right for
Anemia
New York Medical College 50
Large-scale testing (Phase 3)WithdrawnNCT00384657
What this trial is testing

Intravenous Iron in Patients With Severe Chronic Heart Failure and Chronic Kidney Disease

Who this might be right for
Chronic Kidney DiseaseChronic Heart FailureAnemia
Anemia Working Group Romania
Testing effectiveness (Phase 2)Study completedNCT04835519
What this trial is testing

Phase I/II Study of Enhanced CD33 CAR T Cells in Subjects With Relapsed or Refractory Acute Myeloid Leukemia

Who this might be right for
Acute Myeloid LeukemiaRelapse LeukemiaRefractory Acute Myeloid Leukemia
Beijing Boren Hospital 5
Post-approval studies (Phase 4)UnknownNCT00838019
What this trial is testing

Intrabone Cord Blood Transplantation

Who this might be right for
Hematological Malignancies
Hospital Clinic of Barcelona 10
Testing effectiveness (Phase 2)Study completedNCT03126019
What this trial is testing

INCB050465 in Relapsed or Refractory Follicular Lymphoma

Who this might be right for
Lymphoma
Incyte Corporation 126
Testing effectiveness (Phase 2)Looking for participantsNCT07372365
What this trial is testing

Orelabrutinib as Consolidation and Maintenance Therapy in Treatment-Naïve MZL.

Who this might be right for
Marginal Zone Lymphoma (MZL)
The First Affiliated Hospital of Soochow University 23
Not applicableEnded earlyNCT04136665
What this trial is testing

Physical Activity Adapted at Home Supervised by Videoconferencing in Post-cancer for Children / AYA Treated for Leukemia (ONCOPED SAPATIC)

Who this might be right for
Leukemia
University Hospital, Montpellier 2
Large-scale testing (Phase 3)Looking for participantsNCT06345365
What this trial is testing

MA+AZA Regimen for the Treatment of Newly Diagnosed Acute Myeloid Leukemia (AML)

Who this might be right for
Acute Myeloid Leukaemia
Zhongnan Hospital 154
Testing effectiveness (Phase 2)Study completedNCT00860600
What this trial is testing

Safety and Efficacy Study of PG2 to Treat Idiopathic Thrombocytopenic Purpura (ITP) Patients

Who this might be right for
Idiopathic Thrombocytopenic Purpura (ITP)
PhytoHealth Corporation 14
Testing effectiveness (Phase 2)Study completedNCT00002907
What this trial is testing

Bryostatin 1 in Treating Patients With Relapsed Multiple Myeloma

Who this might be right for
Multiple Myeloma and Plasma Cell Neoplasm
Barbara Ann Karmanos Cancer Institute
Testing effectiveness (Phase 2)UnknownNCT00568607
What this trial is testing

Study on the Combination Regimen of Dexamethasone Ifosfamide Cisplatin Etoposide in Patients With NK/T Cell Lymphoma

Who this might be right for
Lymphoma
Fudan University 60
Not applicableNot Yet RecruitingNCT05371392
What this trial is testing

Polymorphism of ITGA4 Gene in Chronic Lymphocytic Leukemia

Who this might be right for
Chronic Lymphocytic Leukemia
Sohag University 80
Not applicableUnknownNCT03745456
What this trial is testing

Hemostasis Profile in Patients With Severe Subarachnoid Hemorrhage

Who this might be right for
Subarachnoid HemorrhagePlatelet DysfunctionCoagulation Disorder
Hospitales Universitarios Virgen del Rocío 50
Very early researchUnknownNCT03728322
What this trial is testing

IHSCs With the Gene Correction of HBB Intervent Subjests With β-thalassemia Mutations

Who this might be right for
Thalassemia
Allife Medical Science and Technology Co., Ltd. 12
Early research (Phase 1)UnknownNCT03015922
What this trial is testing

Viral Immunotherapy in Relapsed/Refractory Multiple Myeloma

Who this might be right for
Multiple Myeloma
University of Leeds 4
Large-scale testing (Phase 3)Study completedNCT03976102
What this trial is testing

Compare Efficacy, Safety, and Immunogenicity of Proposed Rituximab Biosimilar (DRL_RI) With MabThera® in LTB Follicular Lymphoma

Who this might be right for
Follicular Lymphoma
Dr. Reddy's Laboratories Limited 317
Load More Results